Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The FcεRI/Fel d 1–IgE complex is a tripartite molecular assembly central to immediate-type allergic responses. FcεRI (high-affinity IgE receptor) is a multimeric, cell surface receptor—expressed mainly on mast cells and basophils—where its extracellular α chain captures the Fc region of IgE. Fel d 1 is the dominant cat allergen, a uteroglobin-like protein, which binds to allergen-specific IgE. Upon exposure to Fel d 1, preformed Fel d 1–IgE complexes cross-link FcεRI on sensitized effector cells, inducing rapid degranulation and inflammatory mediator release, the hallmark of allergic inflammation. This molecular complex is the principal driver of cat-induced allergy and serves as a key target for both biologic therapies (e.g., anti-IgE antibodies, Fel d 1-blocking antibodies) and diagnostic approaches in allergy medicine. Targeting the interactions within this complex has been at the heart of recent advances in allergen-specific immunotherapy and biologics for allergy and asthma. The term "FcεRI/Fel d 1-IgE complex" is not a standard single receptor or protein but denotes the pathophysiologically critical molecular assembly for cat allergy and allergic asthma research and therapy. The canonical targets are usually defined separately: "High-affinity immunoglobulin E receptor" (FcεRI) and "Fel d 1" (cat allergen). The complex is of direct therapeutic interest because it is where inhibition can block allergic inflammation at the effector stage.
IgE binding blockade: Prevent binding of IgE to FcεRI or to Fel d 1, inhibiting receptor cross-linking and cell activation. Allergen neutralization: Fel d 1-specific IgG antibodies outcompete IgE, thus blocking the pathway and preventing mast cell activation. Desensitization: Immunotherapy aims to induce tolerance by gradual exposure to Fel d 1 epitopes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High-affinity immunoglobulin E receptor complex bound to Fel d 1-IgE (FcεRI/Fel d 1-IgE complex).